BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20303840)

  • 1. Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT.
    Puoti C; Guarisco R; Spilabotti L; Bellis L
    Dig Liver Dis; 2010 Oct; 42(10):745. PubMed ID: 20303840
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N; Marcellin P
    Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels.
    Itoh Y; Morita A; Nishioji K; Narumi S; Toyama T; Daimon Y; Nakamura H; Kirishima T; Okanoue T
    J Viral Hepat; 2001 Sep; 8(5):341-8. PubMed ID: 11555191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.
    Sagnelli E; Coppola N; Marrocco C; Onofrio M; Sagnelli C; Coviello G; Scolastico C; Filippini P
    J Clin Virol; 2006 Mar; 35(3):317-20. PubMed ID: 16316779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.
    Colombatto P; Ciccorossi P; Maina AM; Civitano L; Oliveri F; Coco B; Romagnoli V; Bonino F; Brunetto MR
    Clin Pharmacol Ther; 2008 Aug; 84(2):212-5. PubMed ID: 18388885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
    Shindo M; Okuno T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
    Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
    HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
    Puoti C; Bellis L; Guarisco R; Dell' Unto O; Spilabotti L; Costanza OM
    Eur J Intern Med; 2010 Apr; 21(2):57-61. PubMed ID: 20206870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of alanine aminotransferase during hepatitis C virus treatment.
    Ribeiro RM; Layden-Almer J; Powers KA; Layden TJ; Perelson AS
    Hepatology; 2003 Aug; 38(2):509-17. PubMed ID: 12883496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels.
    Naito M; Hayashi N; Hagiwara H; Hiramatsu N; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Apr; 19(4):871-5. PubMed ID: 8138259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy.
    Nagasaka A; Hige S; Tsunematsu I; Yoshida J; Sasaki Y; Matsushima T; Asaka M
    J Med Virol; 1996 Nov; 50(3):214-20. PubMed ID: 8923285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.